Sonoma Pharmaceuticals Inc Capital Reinvestment Ratio
Sonoma Pharmaceuticals Inc capital reinvestment ratio. Sonoma Pharmaceuticals Inc (SNOA) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($565.00K) in capital expenditures ($2.00K). Check Sonoma Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sonoma Pharmaceuticals Inc (2013–2013)
Capital reinvestment ratio of Sonoma Pharmaceuticals Inc from 2013 to 2013. This chart tracks Sonoma Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Sonoma Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Sonoma Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2013–2013)
Sonoma Pharmaceuticals Inc capital reinvestment ratio by year from 2013 to 2013. For the full cash flow conversion analysis, see SNOA operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.22x | $1.15 Million | $257.00K | — |